Virginia Drug Discovery Consortium
The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:
To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.
To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.
To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.
EVENTS
VirginiaDrugDiscoveryRx: CoronaVirus Therapeutics, Present and Future
Virtual Symposium- May 26 – 27, 2021
KEYNOTE talks from leaders in COVID-19 therapeutics discovery and future
FREE or minimal registration costs for all attendees
MORE INFORMATION
NEWS
VaDDC Executive Committee Member, Beth Sharlow Receives Promotion at UVA
Dr. Elizabeth Sharlow has been promoted to Professor of Research in Pharmacology effective July 1, 2020. More about Dr. Sharlow
Virginia Company, Phlow Corp. Awarded $354 million to Produce Ingredients for Covid-19 Drugs
A new Richmond-based pharmaceutical manufacturing company has received a $354 million federal contract to make the active ingredients for more than a dozen medicines used to treat patients with COVID-19. And the ingredients will be made at a pharmaceutical plant in...
Virginia Bio Names John Newby CEO
Virginia Bio announces John Newby will become CEO of Virginia Bio starting August 5, 2019. John will be stepping down as Commissioner of the Virginia Department of Veterans Services, where for the last 7 years he led this 800-member Agency located across more than 40...
AFFILIATES
Want to work with us?
If you are interested in supporting this initiative, please contact us.